Prevention and Treatment Strategies for Alzheimer's Disease: Focusing on Microglia and Astrocytes in Neuroinflammation

被引:0
|
作者
Zhang, Shenghao [1 ]
Gao, Zhejianyi [2 ]
Feng, Lina [1 ,3 ]
Li, Mingquan [1 ]
机构
[1] Changchun Univ Chinese Med, Affiliated Hosp 3, Dept Neurol, Changchun 130021, Jilin, Peoples R China
[2] Fushun Hosp Chinese Med, Dept Orthopaed, Fushun 113008, Liaoning, Peoples R China
[3] Shandong First Med Univ, Affiliated Hosp 2, Shandong Key Lab TCM Multitargets Intervent & Dis, Tai An 271000, Shandong, Peoples R China
关键词
alzheimer's disease; neuroinflammation; microglia; astrocyte; review; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; REACTIVE ASTROCYTES; TREM2; DEFICIENCY; AMYLOID-BETA; MOUSE MODEL; MONOCARBOXYLATE TRANSPORTERS; COGNITIVE DECLINE; NEURON; TAU;
D O I
10.2147/JIR.S483412
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Alzheimer's disease (AD) is a fatal neurodegenerative disease characterized by its insidious onset and progressive development, making it the most common form of dementia. Despite its prevalence, the exact causes and mechanisms responsible for AD remain unclear. Recent studies have highlighted that inflammation in the central nervous system (CNS) plays a crucial role in both the initiation and progression of AD. Neuroinflammation, an immune response within the CNS triggered by glial cells in response to various stimuli, such as nerve injury, infection, toxins, or autoimmune reactions, has emerged as a significant factor alongside amyloid deposition and neurofibrillary tangles (NFTs) commonly associated with AD. This article aims to provide an overview of the most recent research regarding the involvement of neuroinflammation in AD, with a particular focus on elucidating the specific mechanisms involving microglia and astrocytes. By exploring these intricate processes, a new theoretical framework can be established to further probe the impact of neuroinflammation on the development and progression of AD. Through a deeper understanding of these underlying mechanisms, potential targets for therapeutic interventions and novel treatment strategies can be identified in the ongoing battle against AD.
引用
收藏
页码:7235 / 7259
页数:25
相关论文
共 50 条
  • [41] Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress
    Gandy, Sam
    DeKosky, Steven T.
    ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 367 - 383
  • [42] Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease
    T. Hamaguchi
    K. Ono
    M. Yamada
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1538 - 1552
  • [43] Treatment strategies in Alzheimer's disease
    Winblad, B.
    Nordberg, A.
    Jelic, V.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 63 - 63
  • [44] Treatment strategies in Alzheimer's disease
    Tariska, P
    BASIC AND CLINICAL SCIENCE OF MENTAL AND ADDICTIVE DISORDERS, 1997, (167): : 232 - 234
  • [45] Astrocytes, Microglia, and Parkinson's Disease
    Joe, Eun-Hye
    Choi, Dong-Joo
    An, Jiawei
    Eun, Jin-Hwa
    Jou, Ilo
    Park, Sangmyun
    EXPERIMENTAL NEUROBIOLOGY, 2018, 27 (02) : 77 - 87
  • [46] Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?
    Piirainen, Sami
    Youssef, Andrew
    Song, Cai
    Kalueff, Allan V.
    Landreth, Gary E.
    Malm, Tarja
    Tian, Li
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 77 : 148 - 164
  • [47] Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation
    Anwar, Shehata
    Rivest, Serge
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (04) : 331 - 344
  • [48] Neuroinflammation and Alzheimer's disease
    Eikelenboom, P
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 15 - 19
  • [49] Neuroinflammation in Alzheimer's Disease
    Onyango, Isaac G.
    Jauregui, Gretsen V.
    Carna, Maria
    Bennett, James P.
    Stokin, Gorazd B.
    BIOMEDICINES, 2021, 9 (05)
  • [50] Neuroinflammation in Alzheimer's disease
    Heneka, Michael T.
    Carson, Monica J.
    El Khoury, Joseph
    Landreth, Gary E.
    Brosseron, Frederic
    Feinstein, Douglas L.
    Jacobs, Andreas H.
    Wyss-Coray, Tony
    Vitorica, Javier
    Ransohoff, Richard M.
    Herrup, Karl
    Frautschy, Sally A.
    Finsen, Bente
    Brown, Guy C.
    Verkhratsky, Alexei
    Yamanaka, Koji
    Koistinaho, Jari
    Latz, Eicke
    Halle, Annett
    Petzold, Gabor C.
    Town, Terrence
    Morgan, Dave
    Shinohara, Mari L.
    Perry, V. Hugh
    Holmes, Clive
    Bazan, Nicolas G.
    Brooks, David J.
    Hunot, Stephane
    Joseph, Bertrand
    Deigendesch, Nikolaus
    Garaschuk, Olga
    Boddeke, Erik
    Dinarello, Charles A.
    Breitner, John C.
    Cole, Greg M.
    Golenbock, Douglas T.
    Kummer, Markus P.
    LANCET NEUROLOGY, 2015, 14 (04): : 388 - 405